Where to Buy GHK-Cu in Australia (Research-Grade Guide)

The short answer

GHK-Cu, also written as copper tripeptide-1, is a copper complex of the tripeptide glycyl-L-histidyl-L-lysine. In Australia it is commonly supplied to researchers and laboratories as a research-use-only (RUO) material. When purchased for research, buyers typically focus on documented identity and purity rather than any human application.

At the time of writing, GHK-Cu does not appear as a specific entry in the Poisons Standard schedules, and there is no GHK-Cu research powder registered as a therapeutic good on the Australian Register of Therapeutic Goods (ARTG). This is general information only and not legal advice. Regulatory positions can change, so verify current status with primary sources before you buy.

What GHK-Cu is

GHK-Cu is the copper(II) complex of a small tripeptide made of three amino acids: glycine, L-histidine and L-lysine. In cosmetic ingredient naming it is listed under the INCI name copper tripeptide-1. The tripeptide has a strong binding affinity for copper, which is central to its chemical identity.

The peptide was first isolated from human blood plasma by researcher Loren Pickart in 1973, and the glycyl-L-histidyl-L-lysine structure was confirmed in later work. It is described in the literature as a naturally occurring molecule found in human plasma, with reported levels that are higher in younger adults and lower in older adults. These are observations from the scientific literature, provided here for background only.

Common identifiers

• Chemical description: copper complex of glycyl-L-histidyl-L-lysine
• INCI (cosmetic) name: copper tripeptide-1
• Short forms often seen: GHK-Cu, GHK copper

Regulatory status in Australia

Two points are worth separating carefully. First, scheduling: based on public sources, GHK-Cu is not listed as a specific named entry in the Australian Poisons Standard schedules. The absence of a specific listing is not the same as a positive approval, and related or broader classifications may still apply. Confirm the current Poisons Standard text directly before relying on this.

Second, therapeutic registration: there is no GHK-Cu research powder entered on the ARTG as a registered or listed medicine. A product marketed with therapeutic claims would generally require assessment by the Therapeutic Goods Administration. The TGA has previously raised public concerns about unapproved peptide products in general, so a neutral, claim-free, research-use framing is the appropriate lane for a research compound.

What research-use-only means

Research-use-only (RUO) is a supply and labelling framing indicating that a material is intended for laboratory research and is not supplied for human or veterinary use, not for consumption, and not as a medicine, food or cosmetic. Reputable suppliers label research peptides this way and expect buyers to be researchers or organisations handling materials under appropriate conditions.

Under an RUO framing, the questions that matter are about identity, purity, documentation and handling, not about effects in people. This guide follows that framing and deliberately does not describe dosing, protocols or outcomes.

What RUO framing excludes

• No human or animal use and no consumption
• No therapeutic, cosmetic or efficacy claims
• No dosing instructions or usage protocols

How buyers assess quality

For a research compound, quality is a documentation question. The core document is the Certificate of Analysis (CoA), which records the tested identity and purity of a specific batch. A CoA is most useful when it is tied to a batch or lot number that matches the vial you receive.

Signals buyers commonly look for

• A batch-specific Certificate of Analysis, not a generic brochure
• Purity measured by an analytical method such as HPLC, often paired with mass spectrometry (MS) for identity
• A batch or lot number on both the CoA and the label
• Third-party or independent lab testing rather than supplier claims alone
• Clear storage and handling information appropriate to a peptide powder

Reconstitution and storage are handling topics rather than usage topics. In a research setting these are factual logistics: peptide powders are generally kept cool and dry, and storage conditions are recorded against the batch. None of this implies any application in people.

Anti-doping (WADA) context

For readers in a sport-adjacent research context, note that public sources indicate GHK-Cu does not currently appear as a named substance on the World Anti-Doping Agency (WADA) Prohibited List. However, WADA frameworks include broad catch-all categories for non-approved substances, so a material not being named is not a guarantee of permitted status in sport.

Anti-doping rules change annually and are interpreted case by case. Anyone whose work touches tested sport should check the current WADA list and consult the relevant anti-doping authority directly rather than relying on a general guide.

A neutral buying checklist

If you are sourcing GHK-Cu as a research material in Australia, the following neutral checklist keeps the focus on compliance and documentation.

Before you buy

• Confirm the supplier presents the material as research-use-only without therapeutic or cosmetic claims
• Request a batch-specific Certificate of Analysis and check the method used for purity
• Verify the batch or lot number matches between the CoA and the product label
• Confirm identity data is provided, for example mass spectrometry alongside HPLC purity
• Check that storage, handling and labelling information is clear
• Independently verify the current regulatory and anti-doping position from primary sources

Frequently asked questions